Genital Warts Epidemiology Forecast 2025-2034

Genital warts are considered one of the most common sexually transmitted infections and are caused by certain strains of human papillomavirus (HPV). Approximately 400,000 people get genital warts each year, with most of the patients in their late teens and twenties. People assigned male at birth are at a slightly higher risk of getting the condition.

Genital Warts Epidemiology Forecast Report Coverage

The “Genital Warts Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of genital warts. It projects the future incidence and prevalence rates of genital warts across various populations. The study covers age and type as major determinants of the genital warts-affected population. The report highlights patterns in the prevalence of genital warts over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of genital warts in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Genital Warts: Disease Overview

Genital warts are a prevalent sexually transmitted infection caused by certain types of the human papillomavirus (HPV), primarily HPV-6 and HPV-11. They appear as small, flesh-colored, or gray growths in the genital or anal area. Genital warts can cause itching, discomfort, or mild pain, but can also be asymptomatic. The virus can spread through direct skin-to-skin contact during vaginal, anal, or oral sex with an infected partner. A weakened immune system and having unprotected sex or multiple sexual partners can increase an individual's risk of getting the infection.

Genital Warts: Treatment Overview

Treatment for genital warts cannot eliminate the underlying HPV infection but can help in managing symptoms, preventing recurrence, and removing visible lesions. Prescription creams like imiquimod or podophyllotoxin are commonly used to target warts tissue. Cryotherapy is widely used for freezing warts with liquid nitrogen. For larger or more stubborn lesions, electrocautery helps in burning off warts with the help of an electric current. Laser therapy is recommended for recurrent or widespread warts.

Epidemiology

The genital warts epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for genital warts by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for genital warts and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• In the United States, the incidence of genital warts is estimated to be 1%, with a 50% lifetime risk of infection in sexually active individuals.
• Around 1 in 3 men aged over 15 years are infected with at least one genital human papillomavirus strain, according to a study published in The Lancet Global Health (2023).
• The prevalence of genital human papillomavirus (HPV) infections is estimated to be between 10% to 20%, with clinical manifestations observed in about 1% of the population.
• Studies show that around 80% of the people infected with genital HPV are aged between 17 and 33, with the peak age category being 20 to 24.

Country-wise Genital Warts Epidemiology

The genital warts epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of genital warts varies significantly between countries due to differences in the prevalence of human papillomavirus, vaccination rates, sexual behaviors, healthcare access, and public health initiatives, among others. In the United States, nearly 79 million people are infected by human papillomavirus (HPV), with HPV 6 and HPV 11 strains causing genital warts.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of genital warts based on several factors.
• Genital Warts Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population, and the unmet needs of genital warts are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of genital warts epidemiology in the 8 major markets?
• What will be the total number of patients with genital warts across the 8 major markets during the forecast period?
• What was the country-wise prevalence of genital warts in the 8 major markets in the historical period?
• Which country will have the highest number of genital warts patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of genital warts during the forecast period of 2025-2034?
• What are the currently available treatments for genital warts?
• What are the disease risks, signs, symptoms, and unmet needs of genital warts?

This product will be delivered within 3-5 business days.